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Background: Children with cancer, parents, and clinicians, face difficult decisions when cure is no longer possible.
Little is known about decision-making processes, how agreement is reached, or perspectives of different actors.
Professionals voice concerns about managing parental expectations and beliefs, which can be contrary to their
own and may change over time. We conducted the first systematic review to determine what constitutes best
medico-legal practice for children under 19 years as context to exploring the perspectives of actors who make
judgements and decisions when cancer treatment is no longer curative.
Methods: Theory-informed mixed-method thematic systematic review with theory development.
Results: Eight legal/ethical guidelines and 18 studies were included. Whilst there were no unresolved dilemmas,
actors had different perspectives and motives. In line with guidelines, the best interests of the individual child
informed decisions, although how different actors conceptualized ‘best interests’ when treatment was no longer
curative varied. Respect for autonomy was understood as following child/parent preferences, which varied from
case to case. Doctors generally shared information so that parents alone could make an informed decision. When
parents received reliable information, and personalized interest in their child, they were more likely to achieve
shared trust and clearer transition to palliation. Although under-represented in research studies, young people’s
perspectives showed some differences to those of parents and professionals. For example, young people preferred
to be informed even when prognosis was poor, and they had an altruistic desire to help others by participating
in research.
Conclusion: There needs to be fresh impetus to more effectively and universally implement the ethics of
professionalism into daily clinical practice in order to reinforce humanitarian attitudes. Ethical guidelines and
regulations attempt to bring professionals together by articulating shared values. While important, ethics training
must be supported by institutions/organizations to assist doctors to maintain good professional standards. Findings
will hopefully stimulate further normative and descriptive lines of research in this complex under-researched field.
Future research needs to be undertaken through a more deliberative cultural lens that includes children’s and
multi-disciplinary team members’ perspectives to more fully characterize and understand the dynamics of the
decision-making process in this specific end-of life context.
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Decision-making at its best combines the highest quality
research evidence on the benefits and risks of various
treatments, doctor clinical expertise and judgement, and
patient and family views, opinions and preferences. This
approach to decision-making is casuistic in the sense that
it acknowledges the uniqueness of the individual (the
course of the disease, values, context and the physiological
idiosyncrasies) and prevents a pure rule-based method for
assigning diagnoses, prognosis and selecting treatment
alternatives [1-3]. Nevertheless, in many cases of clinical
practice, cancer care is guided by protocols and guide-
lines, and many clinicians follow algorithms which are
rule-based. Rules, guidelines, and algorithms, are useful
to the deliberative process, but casuistic judgment is ab-
solutely necessary.
In areas of practice such as children’s cancer care, there
is increasing evidence about what works in terms of treat-
ment, but there is still significant uncertainty about prog-
nosis. Childhood cancer illness trajectories are constantly
extending resulting in many children outliving original
prognostic predictions. This uncertainty means that the
decision-making process needs to be casuistic and opti-
mized and adjusted to the situation of each child and their
specific circumstances. Children, and young people in par-
ticular, present another level of complexity as in most legal
systems they are not able to consent until around the age
of 16 years (country specific legislation applies) and may
or may not agree with their doctors or parents. In these
circumstances decision-making, especially when treatment
is no longer curative, is particularly complex and highly
challenging.
In most scenarios doctors, nurses, parents, children
and young people, can come to a shared agreement on a
plan of care. Nonetheless, clinicians are aware that par-
ental expectations and beliefs can change over time and
are subject to multiple external influences that may be
contrary to their own. Clinicians know that managing ex-
pectations can be challenging and the decision-making













To entrust the child’s
treatment to a banne
German doctor.
Case 2, Surrey (UK),
2007 [5]
8 Wilms tumour To halt the last few
treatments of radiothe
as child had had enou
Case 3, London
(UK) 2013 [6]
7 Medulloblastoma To prevent her child r
radiotherapy as she d
believe in its efficacy.stressful if expectations and beliefs are not shared [3]. Al-
though infrequent, situations can arise whereby children
and young people, and or their parents, may not agree
with the proposed medical plan and decisions are referred
to the High Court for a judgement. By way of illustration,
three legal cases are presented in Table 1. In all these
cases, the parents declined or withdrew consent to stand-
ard treatment for their children with favourable prognosis.
In one case, the child asked her mother to halt standard
treatment. In all of these cases treatment was ordered over
parental objections and over the child’s dissent [4-6]. We
found no recent legal cases referred to the Courts in
England and Wales to determine care options when treat-
ment was no longer considered curative, which might help
with better understanding about the decision-making
process. In countries where there is not a medico-legal
framework, decisions can sometimes be referred to clinical
ethics committees, and where neither exists decision-
making can be especially challenging. In this context, ‘law’
and ‘medico-legal framework’ are not confined to a spe-
cific jurisprudential framework but instead incorporate
international ethical guidelines and declarations, statutory
regulations and departmental guidance [7]. Hence, the
world ‘law’ also can be thought of as an expression of eth-
ical and moral standards. This spectrum of ‘law’ obviously
entails variable impact and outcomes. For example, statu-
tory regulations would be enforceable but they may not be
binding on courts.
Why is a review needed?
Little is known about the views and experiences of the
various actors leading to, or how they came to, a shared
agreement when children’s cancer treatment is no longer
curative. Scoping of the literature found no relevant
published systematic review. The purpose of this review
is therefore to explore these issues in greater depth. The
review is both timely and important, and evidence is
urgently needed to better understand the support that
clinicians, children, young people and families need in
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http://www.biomedcentral.com/1471-2431/14/124high quality theory-informed synthesis of evidence will
help policy makers and professionals to determine how to
improve end-of-life care of children and their families.
Conceptual framework
Howard’s descriptive theoretical decision analysis model
[8] originally evolved from statistical decision theory.
Howard subsequently laid out a process for solving deci-
sion problems and described a decision analysis cycle
[8]. Decision analysis is primarily a prescriptive discip-
line, built on normative and descriptive foundations [1].
The prescriptive perspective focuses on recognizing the
limitations and descriptive realities of human judgment.
The normative perspective focuses on rational choice
and normative models. The descriptive perspective fo-
cuses on how real people actually think and behave [1].
Thus, the concepts of Howard’s descriptive theoretical
decision analysis model (Figure 1) played an important
role in understanding decision-making by different actors
in this context. Cognitive psychology (one of the model’s
pillars) has a salient position in understanding human be-
haviour. Decisions are creations of the human mind, and
they are manifested in the way that their ‘cognitive struc-
tures’ are dynamically self-assembled [1]. A human being
(parents, young people, doctors) need data and informa-
tion, and to understand what it means in order to make a
judgement and decision. In this regard, Howard points
out three decision essentials: the information one receives;
the preferences, and the alternatives. Howard’s model en-
ables focussed exploration of the cognitive processes of
decision makers and the decision-making process to de-
velop descriptions of how people actually make judgments
and decisions; how a decision is made in light of expec-
tations, values, uncertainties, objectives, and anticipated
consequences of each possible choice considered. The
model facilitates exploration as to how participants in
the decision-making process formulate both the prob-
lem and the risk-benefit trade-off of their possible solu-
tions, and to identify factors that facilitate or impede the
decision-making process. According to Howard, ‘the prob-
lem frame’ is the declaration by the decision maker(s) of
what decision is under consideration at this time. The
problem frame will influence all elements of the decision
basis. The decision maker(s) decide how far away to
stand, what to include, and what elements define theKey alternatives
and objectives
The problem frameDecision maker, and 
stakeholders involved,
and their values
Figure 1 Howard’s descriptive theoretical decision analysis model [8]figure and the ground. Facilitators and/or barriers to
decision-making will also influence all elements of the
decision basis.
Methods
The following objectives were defined to help organise
the search and synthesis of evidence:
a. To determine what constitutes best practice within
the context of selected medico-legal and ethical
guidelines concerning decision-making towards the
end-of-life in children and young people with
cancer.
b. To explore the evidence about the manner in which
the relevant actors make judgments and decisions
towards the end-of-life in children and young people
with cancer.
c. To identify the factors that facilitate or impede the
decision-making process from the perspective of
each of the relevant actors.
Review design
Initial scoping of the literature showed that a mixed-
method design was most appropriate to address the objec-
tives. The Evidence for Policy and Practice Information
(EPPI) and the EPPI Centre Guidance on synthesis of
mixed-method evidence [9] was selected. The EPPI ap-
proach was adapted to enable quality screening, and
analysis and synthesis of evidence within three separate
synthesis streams: ethical guidelines; quantitative and
mixed-method studies of any type; and qualitative studies
of any type (Figure 2). The analysis of ethical guidelines
was designed to address objective a, the synthesis of other
quantitative and qualitative studies (streams 2 and 3) was
designed to explore objectives b and c. Findings from
streams 1 to 3 were then brought together in an overarch-
ing synthesis to address the review objectives. Further de-
scription of the synthesis processes can be found in the
section on data abstraction and synthesis.
Search strategy
A simple search strategy as advocated by Flemming and
Brings [10] was used to locate studies and is sum-
marised in the SPICE table (Table 2) [11] defining the
setting, perspective, phenomenon of interest, comparisons,Preferences Information Decision Act
Information gathering
.
Figure 2 Flow diagram of the review design and processes.
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http://www.biomedcentral.com/1471-2431/14/124evaluations and methodological approaches. The search
strategy was based on key concepts of interest from the
objectives. The search terms used included the recognised
Medical Subject Heading (MESH). The search terms used
included: Minor OR child*; adolescen* OR youth* ORTable 2 SPICE search strategy





people under 20 years
old with cancer, when











Ethteen*; doctor OR doctor-patient relationship OR clinician;
parent* OR family. These keywords were combined with:
cancer AND terminal* OR end-of-life OR futil* AND
decision-making OR competenc* OR assent AND ethic*













and mixed method evidence.
Mixed method
Guidelinesical guidelines.
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PubMed, Web of Science (Social Science Citation
Index), SciELO, The Cochrane Library, Lexis (legal data-
base), Lawtel (legal database), ASSIA (legal database),
and Greynet, were searched electronically. In addition,
the Web sites of World Health Organization, UNICEF,
World Medical Association, European Union, and British
Medical Association, were also searched. These searches
were focused upon studies published and ethical guide-
lines launched between 1988 and 2012. These dates were
chosen because of the date when the doctrine to respect
the autonomy of patients emerged in international legis-
lation. The first seminal publication on the topic of chil-
dren’s participation in clinical decision-making is the
United Nations Convention on the Rights of the Child
published in 1989. Yet, even before that, the European
charter for children in hospital, 1988, affirmed children’s
right to informed participation in decision-making. The
electronic searches were supplemented with hand search-
ing of key journals, such as: journal of clinical oncology,
paediatrics, and palliative medicine. Inclusion criteria in-
cluded: (a) Key selected ethical guidelines (limited to a pur-
posive sample from the United Kingdom, Pan European
Union, World Medical Association and UNICEF). (b)
Quantitative, mixed-method, and qualitative research
studies of any type if they reported views, experiences
and decision-making by children and/or young people
under 19 years with cancer when treatment was no longer
curative, and/or by their parents and/or their primary on-
cologists and/or the clinicians involved. (c) Publications in
English and Spanish language. The search for key selected
ethical guidelines was purposively limited in order to ex-
tract key tenets of international law to serve as context for
interpreting evidence from published studies.
The rationale for primarily focusing on decision-making
with young people under 19 years reflects typical health
service configuration in the UK and Europe, whereby
children’s cancer services are typically commissioned for
children and young people under 19 years. As previously
described, in most legal systems young people are not able
to consent until around the age of 16 years (country spe-
cific legislation applies), and between age 16 and 18 years
parents are frequently involved in supporting their child’s
decision-making, especially if their child has lived with a
cancer diagnosis for some time. Consequently, regulations
and guidelines have sought to protect children and young
people in this age range.
Terminology commonly changes from ‘children’ to
‘young people’ around age thirteen, although ‘children’ is
commonly used as a term to describe the entire age
range. “Youth” is a more fluid category than a fixed age-
group. UNESCO uses different definitions of “youth” de-
pending on the context. For activities at international level,
UNESCO uses the United Nations universal definition,and defines “youth” as those persons between the ages of
15 and 24 years. For activities at national level, “youth”
may be understood in a more flexible manner so we opted
to primarily focus on under 19 years in line with health ser-
vice commissioning by age group, with additional flexibil-
ities to explore perceptions up to age 20 years in studies
that primarily mapped onto the under 19 year target age
group [12].
Search outcome
The initial electronic searches identified 131 citations
(Figure 2). From these citations, the titles and abstracts
were reviewed by EV and checked by JN, of which 55 ci-
tations required a full document screen to determine if
they met the inclusion criteria. It was unclear whether
these studies targeted decision-making processes, paedi-
atric oncologists and other clinicians, children with can-
cer, and treatment futility. Hand searching identified 6
further research studies that required a full document
screen. Eighteen out of 55 studies met the inclusion cri-
teria and were included in this review. Eight guidelines
that established criteria to determine which norms should
govern ‘best practice’ regarding decision-making towards
end-of-life in children and young people with cancer were
identified.
Quality assessment
Studies were appraised within each stream separately
using the relevant versions of the Critical Appraisal Skills
Programme tool (CASP) [13]. Any disagreements were re-
solved through discussion between reviewers. None of the
18 included studies were excluded although there were
variations in the quality reporting (“Additional file 1”). No
study had a fatal flaw (the threshold for exclusion). Guide-
lines were not appraised critically.
Data extraction and synthesis
EV extracted and summarized evidence by stream in ta-
bles and templates adapted from National Institute for
Health and Clinical Excellence (NICE) guidance [14].
Guidelines were subject to content analysis [15] and key
guiding principles underpinning ethical decision-making
were extracted and summarized in Table 3. Key ethical
principles were then used as context to define best practice
when interpreting evidence. Quantitative, mixed-method
and qualitative streamed and extracted data were summa-
rized in Tables 4 and 5. JN checked data extraction and
any queries were resolved by consensus with EV.
It was not possible to perform a meta-analysis as we did
not find any clinical trials and observational studies were
heterogeneous and did not permit statistical pooling.
Therefore, a thematic synthesis approach [42] was used
to synthesise evidence from streams 2 and 3. We under-
took a thematic synthesis with 18 studies (by stream: 10
Table 3 Summary table of international laws, guidelines and regulations upon ethical decision-making in relation to children
Organization or country Laws (L) Specific provision concerning
withholding and withdrawing
treatment.
Consent requirements Competence Standard for surrogate
decision-makingGuideline (G)
Regulation (R)
UNICEF [G] The United Nations
Convention on the Rights of
the Child (1989). [16]
___________ Child means a person <18 years of
age unless, under the law applicable
to the child, majority is attained
earlier.
___________ The child’s best interests.
Article 1. Articles 3, 18
The views of the child being given
due weight in accordance with the
age and maturity of the child. Article
12.
World Medical Association [G] Declaration of Ottawa on
the right of the child to
health care (1998). [17]
To protect every child from
unnecessary diagnostic,
procedures, treatment…
The wishes of the child being given
due weight in accordance with her/
his capacity of understanding.
Principle 9.
“The mature child, in the judgment
of the physician, is entitled to make
his/her decisions about healthcare.”
Principle 9.
The child’s best interests.
Principles 4,11
Principle 4.
European Union [G] European Convention on
the exercise of Children’s
Rights (1996). [18]
___________ Child means a person <18 years of
age unless under the law applicable
to the child, majority is attained
earlier.
It is left to States (the judicial and
administrative authority) to define
the criteria enabling them to
evaluate whether or not children are
capable of forming and expressing
their own views. Articles 3,6.
The child’s best interests.
European Community
Council of Europe
Article 1. Articles 1,3.
Children have the right to express
their own views providing they have
sufficient competence. Articles 1, 3.
European association for
children in hospital
[G] Charter for children in
hospital (1988). [19]
Children shall be protected from
unnecessary medical treatment.
Article 5.
Children have the right to express
their own views providing they have
sufficient competence. Article 4.
___________ ___________
United Kingdom [G] British Medical
Association 2010. [20]
Futility is the legal and ethical
justification for the withdrawal
and withholding of treatment.
Card 7
All people aged ≥16 are presumed
in law to be competent to give their
consent to medical treatment. Card
2In cases of disagreement, the views
of the court should be sought. Card
6
The ability to understand that there
is a choice and consequences
The child’s best interests.
Card 5
The ability to weigh the information
and arrive at a decision.
A willingness to make a choice.
Card 2
[G] General Medical Council.
2010
There is no obligation to give
treatment that is futile and
burdensome. Legal annex.
Child means a person <18 years of
age. Paragraphs 74. Yet they can
consent at 16 years. Legal annex.
To assess capacity Paragraph 74. The child’s best interests.
Paragraphs 74,76,77,81.
GMC’s guidance [21]
To involve children and young
people in decisions Paragraphs 74,79.
In cases of disagreement, the views



















Table 3 Summary table of international laws, guidelines and regulations upon ethical decision-making in relation to children (Continued)
[G] Royal College of
Paediatrics and Child Health
2004. [22]
Brain Death. Young people aged over 16 years
are presumed in law to be
competent to give their consent to
medical treatment, but not
necessarily dissent decisions. Section
2.4 (2.4.1)
The ability to understand
information and to form and express
personal views.
The child’s best interests.
Permanent vegetative state. Section 2.6(2.6.1) Section 2.3(2.3.1.2)
There should be a presumption of
competence, unless a child is
obviously incompetent. Section 2.6
(2.6.1)
The wishes and views of the child




The “no chance” situation. In cases of disagreement, the views
of the court should be sought.
Section 2.3(2.3.1.2)The “no purpose” situation.
The “unbearable” situation.
United Kingdom [L1] The Children Act
(England and Wales) 1989.
___________ Child means a person <16 years of
age. [L2] Section 2(7).
The ability to understand and to
make an informed decision.
The child’s best interests.
[L2] Children Act (Scotland)
1995.
Child ≤12 years of age shall be
presumed to be of sufficient age and
maturity to form a view”. [L2] Section
16(2)
[L1] Section 1(1)
[L3] The Children Order
(Northern Ireland) 1995. [23]
[L1] Section 43(8) and 44(7) [L2] Section 16(1)


















Table 4 Summary table of included quantitative studies
Reference Objective Study design Participants Setting Results Methods/Quality






Cross-sectional study. Parents (n = 62) of children
(n = 58) whose disease had
progressed to the terminal
stage.
1 Hospital: USA Parental reasons for: Interview questions pilot
tested.
─Do not resuscitate status or
terminal care: concern with
quality-of-life (74%) and patient
wishes (67%).
Trained interviewers.Private and separately
semi-structured interviews





Most parents were women.
No sample size estimation.─Phase I Research Controlled
Trial: the need to continue
cancer-directed treatment (71%).
Reasons for both groups of
treatment:
Semantic content analysis.Treatment decisions: The children of these parents
ranged in age from 0.6 to
21.6 years; median,
11.4 years).
─Do not resuscitate or




Parents were the only
decision-makers. To take into account the medical
facts.
To preserve the child’s legacy.
Tomlinson D
et al. 2011. [25]




Cross-sectional study. One parent per child (n = 77;
response rate = 67%) of
children at end-of-life.
1 Hospital: Parental factors: hope, increased





Trained interviewers.Single face to face







No sample size estimation.
No probabilistic sampling.Median age of children was
8.6 years (range, 6.2-





Most parents were women
(78%).
Parents (n = 42, 54.5%), Univariate logistic regression
analysis
Healthcare professionals
(n = 20, 15.6%).
Hypothetical scenario was
presented to parents and
to healthcare
professionals.─Supportive care alone:





Primary oncologist (n = 25).
p < 0.0001
Nurses (n = 97)
Factors of options given
to them:
Social workers (n = 6).





















Table 4 Summary table of included quantitative studies (Continued)
Wolfe J et al.
2000 [26]




Cross-sectional study. One parent per family (n =
103; response rate = 72%) of
children who died of cancer
(median 3 years; range 1.1-
8.0, years after death).
2 Hospitals: USA Parental goal: Interview questions pilot
tested.
─To extent life (n = 87, 84%)
Trained interviewers.
Oncologist goal:
─To lessen suffering (n = 18,
42%).





(k = 0.16; 95% CI −0.11 − 0.42) Regression analysisChildren mean age
10.8 years; SD, 6.7 years old
at death.




Most parents were women
(86%).
Primary oncologist (n = 42;
response rate was not
declared). Most of them were
men (69%).




et al. 2002 [27]
To explore the shift from
cure to palliation.
In-depth history audit of
medical records.
Medical records of 18 (64%)
children who died of cancer.
They ranged in age from 2 to
17 years; median age at
death 10 years old).
1 Hospital: For many families the hope of
cure continued until the child
was close to death.
Pretesting of the audit form




They continued to seek curative
or life extending options.
No sample size estimation.Parents participated in
the decision-making.
Content analysis technique.









103 medical charts from
adolescents who
1 Hospital: USA Timing of end-of-life discussions
occurred very
Pretesting of the instrument
used is
Parents were directly
involved in the end-of-life
decision.
died of cancer. close to death for a significant
number of adolescents.
not reported.
No sample size estimation.
No probabilistic sampling.Children mean age at death
14.4 years; SD, 2.9 years old.
Univariable analysis.
Hilden JM et al.
2001 [29]
─ To explore perceived








All members of American
Society of Clinical
Oncology in the USA,
Canada and the UK.
Barriers: Validated instrument
Multivariate analysis─ Family’s unrealistic
expectations for cure (n = 98,
43%).
─ Family denial of the illness as
terminal (n = 63, 27.6%).
─ To describe the factors
influencing decision-
making.
─ Family conflicts (n = 24, 10.5%).
Factors influencing d-m:
─ Absence of effective therapy
(n = 213, 93.4%)
─ Request by patient/parent(s)


















Table 4 Summary table of included quantitative studies (Continued)




quality care at the end-of-
life for children, as per-
ceived by parents and
physicians.
Cross-sectional survey. One parent per family (n =
144; response rate = 65%) of
children who had died of
cancer (a mean of 3.2 years
after death).






No sample size estimation.
All items of the
questionnaire were
closed ended with Likert
scales.
Physicians’ care ratings depend
on biomedical rather than




Multivariable analysis.Median age of children at
death was 8.9 years (range,
0.3-25.3 years).
No association was found
between parent and physician
care ratings (p = .88).
The majority of interviews
were administered by
telephone.
Most parents were women
(83%).
Child’s primary oncologist
(n = 52; response rate =
100%), most of them were
men (65%).
All participants were
directly involved in the
end-of-life decision.
Edwards KE et al.
2008 [31]




goals during the child’s
end-of-life period were
aligned.
Cross-sectional survey. Pairs of mothers and fathers
(n = 38; response rate = 56%)
were interviewed an average
of 4 years after their child’s
death.
2 Hospitals: USA During end-of-life, the lessening
of suffering was the main pri-
mary treatment goal reported.
However, only 34% of couples
agreed on this goal (k = 0.07;
95% CI, 0.20 to 0.44). During the
last month of life, 42% of parents
concurred regarding lessening
suffering (k = .0.35; 95% CI, 0.05
to 0.65). Among discordant pairs,
there was no parental gender
preference for a particular goal.
Interview questions pilot
tested.
Trained interviewers unclear.The majority of interviews
were administered by
telephone. No sample size estimation.
No probabilistic sampling.
Bivariate analysis.Median age of children at
death was 10.3 years (range,
0.9-24 years).
The items of the
questionnaire were
closed ended, yet some
of them requested open-
ended elaboration.
All participants were
directly involved in the
end-of-life decision.






Cross-sectional study. Parents of 48 (Response rate
= 35%) children who died of
cancer (range 3 - 5, years
after death).
6 Hospitals: Germany 64% discussed end-of-life deci-






Depending on whether parents
had had a discussion on
decisions with the team, their
decision on resuscitation differed.
No sample size estimation.





Children mean age 8 years at
death, SD, 4.9 years old.
Fisher exact testMost parents were women
(94%).Treatment decisions: All participants were
directly involved in the
end-of-life decision.─ Cancer-directed treat-


















Table 4 Summary table of included quantitative studies (Continued)
─ Do not resuscitate
(n = 24)
─ Terminal care (n = 6).






they had recognized that
the child had no realistic
chance for cure.
Cross-sectional study. One parent per family
(n = 53) of children who had
died of cancer (a mean of
3.2 years after death).
2 Hospitals: USA The main goals to continue
cancer-directed treatment were:
cure (20%), life extension (22%)
and to lessen suffering (20%).
Interview questions pilot
tested.






No sample size estimation.
Response rate = 64%
31 parents reported that their
child suffered as a result of
cancer-directed treatment.
No probabilistic sampling.Median age of children at
death was 8.9 years (range,
0.3-25.3 years). Multivariable analysis
29 reported that their child had
received little to no benefit.
The majority of interviews
were administered by
telephone.
Most parents were women
(83%).
All participants were
directly involved in the
end-of-life decision.
Hinds P et al.
1997 [34]




Cross-sectional study. Parents (n = 37, response rate
= 44.6%) of children who had
died of cancer (6─24 months
after death).









with parents and face-to
face with healthcare pro-
fessionals. It was then
followed up with a ques-
tionnaire with a Likert re-
sponse option.
No probabilistic sampling.
Oncologist factors: No sample size estimation.
Content analysis andChildren mean age at death
13.4 years; SD, 5.10 years old.




Logistic regressions.Patient’s prognosis and comorbid
conditions.
Gender distribution was not
reported.
Information and opinions from
colleagues.
Healthcare professionals
(16 oncologists, 3 nurses, and
2 chaplains).
All parents were directly



















Table 5 Summary table of included qualitative studies
Reference Objective Study design Participants Setting Results Methods/Quality
Hinds Pet al.
200 [35]
To describe the way in which
decision are made & factors
considered in the decision-
making process
Private semi-structured interviews
within 24 hours to three weeks
of participating in end-of-life
decisions.
One parent per family (n = 11) of
children whose disease had














“Nothing more to do”.
“Believing that my child could
not survive” Data saturation
not reported.
The children of these parents
ranged in age from 1.8 to
19.11 years).
Treatment decisions: Site-specific factors: the child’s




─ Do not resuscitate status or
terminal care (n = 11)
All parents assisted in making a
treatment-related decision.
Most parents were women.
All five Hong Kong parents “felt
forced” to participate in the
decision-making process.
Hinds P et al.
2005 [36]
To identify the end-of-life care
preferences and the factors that
influenced their decisions.
Private and separately, face-to-
face semi-structured interviews
within 7 days of their participa-
tion in end-of-life decisions.
Children (n = 20) aged 10 to






Avoiding adverse effects. Trained
interviewers.
Parental factors: A convenience
sample technique.
Parents (n = 19) The child preferences.




Oncologist (n = 14), Most parents





All participants were directly
involved in the end-of-life
decision.
Patient and family preferences.─DNR status (n = 5),
─Terminal care (n = 7),
─Phase I RCT (n = 8).
Hinds P et al.
2009 [37]
To identify parental definitions of
being a good parent. And the
actions from clinicians that
would be helpful to them in
fulfilling this role.
Private and separately, face-to-
face, semi-structured interviews
within 72 hours of participating
in no curative treatment
decisions.
Parents (n = 62) of children (n =
58) whose disease had
progressed to the terminal stage.
1 Hospital: USA Good parent means: (i) Doing
right by my child. (ii) Making
decisions in the child’s best









The children of these parents
ranged in age from 0.6 to
21.6 years; median, 11.4 years).
Actions from clinicians: Data saturation
not reported.
To know that the child was
receiving the best clinical care.Treatment decisions: Semantic content
analysis.


















Table 5 Summary table of included qualitative studies (Continued)
─Do not resuscitate status or
terminal care (48.3%),
Every theme was reflected in all
three decision types.
Parents participated in the
decision-making.
─Phase I Research Controlled
Trial (51.7%),
Tomlinson D
et al. 2006 [38]
To identify the factors
influencing decision making
about treatment options for end-
of-life.
One focus group. Parents (n = 7) of children (n = 5)
who had died of cancer (from
0.6 to 14 years after death).
















Age of children at death no
declared.
Time, lessening suffering, nothing
more to do, child preferences.
Content analysis.
Factors options: Most parents were women.Treatment offered:
Parents were the decision-
makers.
Child’s quality-of-life, Survival




Percentages per group no
declared.
Hannan J et al.
2005 [39]
To identify the factors
influencing decision making
about final place of care (home
or hospital).
Private and separately open-
ended interviews. Parents were
the only decision-makers.
Parents of children (n = 5) who
had died of cancer (from 1 to
2 years after death).
1Hospital: England Valuing time left, Interview
schedule piloted.









No difference between home
and hospital, other than the
desire to have control
themselves as a family.
Data saturation
not reported.
Gender distribution was not
reported.
Interpretativephenomenological analysis.
The children of these parents
ranged in age from 10 to
19 years).
Place of care decisions:




et al. 2007 [40]
Parents’ approaches to care and
treatment.
Ethnographic study including Parents of 34 children whose
disease had progressed to the
terminal stage.
2 Hospitals: 23 accepted CDT or look on







4 out of 23 cases to whom was
























ended, semi structured inter-
views. Parents were the only
decision-makers.
2 out of 11 cases to whom was
offered only TC agreed.
Data saturation
not reported.
The children ranged in age from






Gender distribution was not
declared.Cancer-directed treatment
(n = 23), Terminal care (n = 11),
Steward JL
et al. 2012 [41]
To describe and explicate the
treatment decision-making
process from the perspectives of
parents.
Private and separately semi
structured interviews, within six
months of participating in major
treatment decision-making.
Parents (n = 15) of children
(n = 13) whose disease had
progressed to the terminal stage.




(i) Doing right by my child. (ii)
Making decisions in the child’s
best interest. (ii) Meeting the
child’s basic needs.
Trained
interviewers.The children of these parents
ranged in age from 3 to 17 years;
median, 10 years.
Most parents were women. Convenience
sampling
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http://www.biomedcentral.com/1471-2431/14/124quantitative studies, 1 mixed method study and 7 quali-
tative studies). It is important to note that the process
of coding primary studies was initially undertaken in an
inductive way. Once data were coded and organized
thematically, we drew on Howard’s descriptive theoret-
ical decision analysis model (Figure 1) as a framework
for understanding decision-making. We used Howard’s
model to focus on the decision process, including fac-
tors that were considered and the anticipated outcomes,
rather than on assessing decision quality (correctness or
appropriateness) [1,8]. We identified decision-makers
and stakeholders involved in the problem, unpickedFigure 3 Factors influencing decision-making and ideas and hypothesis
treatment is no longer curative. Level 3 constructs.their values and their preferences to be used for the de-
cision, and identified key alternatives and objectives and
information available.
The analysis process required each study to be read re-
peatedly to ensure that all concepts were integrated and
the relationships between the concepts of each study were
explored. We used the notion of first order, second order
and third order constructs to analyze and reinterpret the
studies [42]. First order constructs are insights offered by
participants in the original study. All participant quota-
tions that were paraphrased by the original researchers
were extracted as first order constructs. Second-ordergeneration from relevant actor and author perspectives―when
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oped by the original researchers from the first order con-
structs. We described and listed the themes reported by
authors of each original study and made a note of the
number of studies that contributed to each theme. Third
order constructs were derived from the synthesis of evi-
dence across multiple studies. We developed third-order
constructs by analyzing the second-order constructs to
identify new, common themes that emerged from our in-
ductive analysis to address the review objectives. Data
entry and analysis were performed using Atlas/ti version 7
computer software.
Interpreting the entire dataset and developing a new
theoretical framework
Finally, we synthesised evidence from the three streams
(Figure 2) in an overarching fourth narrative synthesis.
We juxtaposed key tenets of best ethical practice in key
selected guidelines (such as ‘best interests’, consent require-
ments, age to assent/consent, etc. described in Table 3)
against the themes from 18 studies using a constant com-
parison technique [15] in order to see the extent to which
these tenets are legally or socially enforced. First levelFigure 4 Theoretical framework of the positive and negative influencconstructs (participant quotes) and second level constructs
(primary research author interpretations) were translated
into the 6 themes (third order constructs) to which we
then added our own ideas and interpretations through on-
going engagement with the evidence and using our expert
knowledge of the field to form hypotheses concerning
what the evidence said about factors influencing decision-
making from relevant actors’ perspectives (Figure 3).
During several subsequent meetings, the authors used
Howard’s model to further inform organisation and inter-
pretation of ideas to help them understand how the rele-
vant actors of the doctor-patient-relationship shaped the
goals, objectives and preferences in treatment decision-
making when cancer treatment is no longer curative, and
over time developed a new theoretical framework to help
caregivers to identify the changes required of them and
for guiding future research (Figure 4).
Results
Key principles and tenets from ethical guidelines (stream 1)
Eight guidelines about decision-making towards the end-
of-life, in children and young people with cancer, were pur-
posively sampled, reviewed and then summarized [16-23]es in the decision-making process.
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tice in accordance with commonly accepted medico-legal
and ethical guidelines. The guidelines selected include
the most comprehensive documents on the substantive
rights and obligations to protect the child patient’s vul-
nerability. Many medical societies worldwide, including
the British Medical Association, are bound to them by
international law.
What constitutes best practice in legal and ethical
guidelines?
Children age 16 to 18 years are presumed to be compe-
tent to give consent to medical treatment as if they were
adult (age 18 years in the UK). However, if both the par-
ents and their child refuse treatment, the court can over-
ride the refusal if it is in the best interest of the child to
do so [4-6]. Children under 16 lack ordinary legal author-
ity to make binding medical decisions, yet they could in
specific circumstances meet functional criteria and be de-
clared competent to do so. In such situations legal argu-
ments support giving decisional authority to the minor
patient [16-18,20-23]. In this group of children, the best
interest of the child is always a primary consideration
(Table 3). Whilst the guidelines outline consistent ethical
principles, there is however an absence of guidance on the
application to real life clinical scenarios.
Actor perspectives and decision-making towards the
end-of-life (streams 2 and 3)
Quantitative studies on actor perspectives included cross-
sectional structured interviews with parents [24-26,30-34]
and with paediatric oncologists [25,26,34], a mailed survey
with paediatric oncologists [29], one in depth history audit
of medical records [27]; and a review of medical charts
[28]. Most of the studies [26,30-34] included bereaved par-
ents 0.6 to 5 years after their child’s death.
Qualitative studies included semi-structured interviews
with parents [35-39,41] and with parents/children/oncolo-
gists [36], one ethnographic study [40], and one focus
group [38]. Only three studies [34,38,39] included be-
reaved parents with 1 to 3 years after their child’s death.
Synthesis of 18 included studies identified six overarch-
ing themes: (i) the flow of information to inform decision-
making; (ii) disclosure of prognosis; (iii) the process by
which doctor-child/parent relationships were developed;
(iv) biomedical aspects and child/family preferences; (v) al-
ternatives of treatment, preferences, and objectives and
goals of their preferences, and (vi) barriers and facilitators
to decision-making.
Information exchange (type, amount, and direction
of information flow processes) All parents recognized
that they had assisted in making a treatment-related de-
cision on behalf on their child [24,27,32,35-41]. Hinds[37] and Steward [41] reported that all US parents will-
ingly assumed the burden because they considered that
it was their job and they never considered shirking this
critical responsibility. However, in a cross-cultural study
(US, Australia and Hong Kong) Hinds [35] found that all
five Hong Kong parents were “feeling forced” to partici-
pate in the decision-making process, thereby showing
that cultural context is an important consideration.
The type and amount of information exchanged be-
tween clinicians and parents, and whether information
flow was really two ways, was not reported. However,
nearly all parents described an interactive process be-
tween themselves and the healthcare team, mostly with
their child’s primary oncologist [26-28,32,35,36,40,41].
Some parents reported that their child’s primary nurse,
or the psychosocial clinician [26,32], or another doctor
[28], were involved at some point in the discussions
about whether their child had no realistic chance of be-
ing cured. Only few parents denied having discussed this
with the clinical team [28,32]. In a few of these cases, it
was reported that a conflict existed involving disagree-
ment between clinicians and parent(s), with the parent(s)
not yet ready to agree to a change in ‘do not resuscitate’
status [28].
Some studies [26,28,30,36,40,41] clearly identified
whether or not the children and young people were
included in the discussion regarding treatment. There was
variability in the degree to which parents elected to in-
volve their child in the decision-making process. Mack
[30] and Steward [41] reported that some parents deliber-
ately excluded their child, either because they felt their
child was too young to participate or to spare even older
children from the burden of participating in the decision.
Among children who were not perceived (by their parents)
to be too young (median age 10 years, range 3—17 years),
the majority received information via direct communica-
tion from the doctor [26,30,36,41]. In contrast, according
to the US parents interviewed, the child’s preference was
of high importance in end-of-life care decision-making
irrespective of the child’s age [24,26,35,36,38,39,41]. The
children’s ages of this group of parents ranged from 0.6 to
21.6 years, with a median of 13.5 years. The studies did
not organise findings by children’s age to shed more light
on age-related decision-making processes and assent and
consent issues. Only one study [36] reported to have inter-
viewed directly a sample of children to identify the factors
that influenced their end-of-life care decisions, the child
participants in this study were aged 10-20 years.
Disclosure of prognosis For parents and young people,
disclosure of prognosis and the process by which doctor-
child/parent relationships were developed were important
when making judgements and decisions towards the end-
of-life in children and young people with cancer. For
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morbid conditions) and child/family preferences regarding
the options that respond to the problem frame figured
most importantly in their decision-making.
Terminal care was defined as cessation of cancer-
directed treatment, which may or may not continue
with aggressive symptom management [24,36,37]. The
term palliative care was used to make reference to the
initiation of palliative measures when there was no lon-
ger a reasonable hope of cure, or to refer to supportive
care [27,38,40]. The terminal stage was reached when,
according to child’s primary oncologist, standard ther-
apy had failed and cure was no longer a possibility
[24-28,30,31,37,38,40]. The terminal stage involved the
prediction and evaluation of outcomes, which were usu-
ally probable rather than certain. The trajectory to death
of those who had reached this stage was lower than or
slightly longer than 3 months [26,28,31,38,40], or in one
study less than 6 months [32]. Some clinicians initiated
disclosures when cancer had recurred and it had less
than 30% chance of cure [25,38,40]. End-of-life period
was defined as the time before death and it was related
to incurable cancer and its terminal stage. End-of-life
discussions more likely occurred in the last 7 days of
life, [28] or late in treatment [34].
Parents and mostly proxy reports of children’s views
showed that irrespective of context they wanted their
doctors to appear interested, listen well, explain clearly,
be open to discussion and achieve verbal agreement with
them [24,27,30,32,34-38,40]. Time to allow other possi-
bilities like a second opinion and/or alternative therapies
[27,35,40] were important during the end-of-life period.
Other factors impacted on the effectiveness of end-of-life
communication, such as the need for hopeful messages
about a possibility for cure, or longer life expectancy, or
related to short term visions of the future, or continued
care, or an indication that the clinician had not given up
(children) and, that they had not given up on their child
(parents) [24-28,31,36-38,40]. The single study conducted
with children and young people [36] showed that they
preferred to be informed even when the prognosis was
poor or treatment was no longer curative.
The process by which doctor-child/parent relation-
ships was developed Trust was the single most import-
ant factor in the decision-making process and there was
variation in trust afforded by parents to doctors. Trust
was in part a product of clinician behaviour. Several par-
ents looked for medical facts that included the trustworthy
doctor’s expertise (clear and understandable information
about their child’s condition) or medical knowledge ob-
tained through research [24,30,32,34-38,41]. Many parents
reported a need to believe that clinicians were giving to
their child the best possible clinical care and that they(parents) could count on clinicians to guide the decision-
making [34-38,40,41].
A few parents acknowledged that they really had no
choice but to trust in individual caregivers and in the
profession of medicine (paediatric oncology specifically)
given their child’s situation [41]. For these parents, trust-
ing doctors and medical knowledge eased the pressure
they felt to make the right decision [41]. Only one par-
ent articulated a lack of trust in her child’s clinical team,
specifically voicing scepticism about the doctor’s motives
for presenting a clinical trial in a positive light in order
to enrol her child. The scepticism towards the motives
of the doctor intensified the difficulty of the decision-
making process for parents [41].
Whilst the evidence suggests that variation in trust is
associated with clinician behaviour, the variation may be
highly individual and reflect a parent’s own health beliefs
concerning the appropriateness of experimental or ‘res-
cue’ therapies or their individual ability to trust others
that predates the child’s illness. The same clinician be-
haviour that is perceived as collaborative and in the best
interest of their child by one parent may be perceived as
intrusive, threatening or experimental treatment by an-
other. Parents also stressed the importance of needing to
be treated as individuals. Parental assessments of doctor
attributes rested, largely, on their perceptions of the doc-
tor’s ability and willingness to contextualize the decision-
making process by framing the end-of-life discussion in
terms of each child’s unique background, characteristics
and life experience [24,35,36,41]. From the parent’s per-
spective the expectation was always that the doctor would
facilitate this process. Both groups (parents and children)
[24] desired that staff should continue to provide thought-
ful care, including emotional care. Parents cited actions,
for example: honesty, caring, sensitivity, and treating each
child uniquely [30,37,38]. There was a noticeable lack of
evidence concerning the wider complexities of decision-
making and the complex beliefs and experiences of par-
ents that could help or hinder the process of developing
trusting relationships with clinicians.
Biomedical aspects and child/family preferences To
all oncologists, the child’s prognosis and comorbid con-
ditions were among the central considerations of their
decision-making [25,26,29,34,36]. This evidenced their
desire to avoid harm and to lessen suffering in the absence
of effective therapy. A survey of 52 paediatric oncologists
and 144 parents showed that the highest doctors’ ratings
of quality of end-of-life care were characterized by ‘little
pain’ and ‘minimal time in the hospital in the last month
of life’, whereas parents’ highest ratings were ‘clear infor-
mation, given in a sensitive caring manner, about what to
expect in the end-of-life-period’ [30]. No association was
found between parent and doctor ratings of quality of
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child/family preferences as important [25,26,29,34,36].
Treatment alternatives, child and family and clinician
preferences and goals Parents and children typically
faced one of two alternative decisions: doing something or
doing nothing. The first was a choice of cancer-directed
treatment, randomized or non-randomized controlled
trial, or terminal care (end-of-life palliative care) with or
without palliative chemotherapy. The second included the
choice of withdrawal or withholding treatment and the de-
cision to not resuscitate. The selection of an option was
based on the decision-maker’s goals and objectives.
Cancer-directed treatment
Parents with inaccurate perceptions of the prognosis or
unrealistic expectations for cure were more likely to
choose aggressive therapies, including cancer-directed
treatment to overcome disease and promote recovery,
than parents with more realistic expectations. The deci-
sion for cancer-directed treatment in the end-of-life care
period occurred more frequently in those parents who
had not had a discussion with the clinical team on the
topic beforehand [27,32] or when trust was not apparent
or shared in the decision-making process [27]. There
were also parents who recognized that cure was unlikely,
and even then they elected to continue cancer curative
treatment. These parents pursued different goals, such as:
to keep hoping [26,27,33,40]; to ensure that everything
had been done [26,33]; to have more time with their child
[40]; or life expectancy extension [26,33]. Few parents re-
ported that the primary goal of cancer-directed treatment
during this period was to lessen suffering [26,31]. In con-
trast, oncologists in surveys mentioned ‘the family choices’
as a primary goal [26,34].
Recruitment to clinical trials
Parents saw their primary goal as advocating for their
child the best chance for a cure [24,36,41]. Deciding to
enrol their child in a trial of experimental treatment was
commonly interpreted by parents as being offered a
chance for cure, albeit sometimes a very slim or even
highly unlikely chance of cure depending on the type of
trial. Within this decision-making scenario parents also
weighed up and considered secondary goals such as pre-
serving the child’s present and future quality of life [41].
Another parental goal included the desire to help others
by means of cancer research [33,36,41]. Young people
reported that for them, their goals were to extend their
life expectancy ―specifically to cure, and to want to
help others by means of cancer research [36]. In the
same study, doctors declared that their goal was wanting
to benefit their patients and others, thereby indicating a
dual purpose in wanting to do the best for individualchildren, but also to use their knowledge and clinical ex-
perience of treating individuals, to advance the care and
treatment for children with cancer generally (ie a greater
good) [36].
Terminal care
All parents that chose terminal care without palliative
chemotherapy (supportive care alone) voiced many rea-
sons, but the most common goal was to pursue their
child’s quality of life, by diminishing the suffering of
their child [24,34-36,38]. The following considerations
were influential factors in their decision-making: valuing
time left [36,38], nothing more left to do [24,35,36,38],
believing that nothing else could really help the child
[34], thinking the child would never get better [34]. The
primary goal for those parents who chose terminal care
with palliative chemotherapy was also their child’s qual-
ity of life, and as a secondary goal to create a sense of
hope for a cure and an extension of life expectancy
[25,38]. The decision to opt for terminal care in the end-
of-life period occurred more frequently in those parents
who had held a discussion with the clinical team on the
topic [24,32,34,35]. The goals typically mentioned by
young people were also focused on their quality of their
life, the avoidance of cancer-directed treatment adverse
effects, the belief that further treatment is futile, the feel-
ing of being ready to die or the experience of having
seen someone else die [36]. Oncologists saw as their pri-
mary goal to avoid harm when there was no other op-
tion or the absence of effective therapy [29,34,36].
Withdrawal, withholding, and do not resuscitate
Young people, parents and clinicians pursued the same
terminal care goals, that is to improve life conditions
with good symptom control and quality of death in this
group of children [24,32,34-37]. A few families consid-
ered the financial cost of further treatment for their
child as a factor that facilitated their decision to forgo
any further active treatment [27].
Place of death
Most children and young people died from disease pro-
gression in a hospital setting [27,28,31,32,39]. The par-
ents’ goal was to be in control at the time their child’s
death [39]. More than a third of 228 paediatric oncolo-
gists surveyed in the US, Canada and UK stated that the
lack of a readily available and easy-to-use palliative care
team or pain service made the delivery of good terminal
care difficult [29].
Barriers and facilitators to decision-making One study
identified the barriers and facilitators to end-of-life
care [29]. Five studies identified the actions from staff
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process [24,34-36,38].
The barriers identified most often according to parents
included: the fondness that staff members showed their
child that made it more difficult (for parents) to make a
decision to stop cancer-directed treatment [35], feeling
forced to decide from alternative care pathway options
[35], not having written information about the drug in a
trial [36], and financial burden [38]. For young people,
the barriers related to the possible toxicities of the ex-
perimental drug being tested in a trial [36]. In contrast,
for oncologists, the barriers were commonly the family
having unrealistic expectations for cure [29], family de-
nial of the illness as terminal [29], and internal family
conflicts [29].
The facilitators most often identified by parents were:
the provision of thoughtful care by staff [24,34-36,38],
trusting the staff [24,34,35], getting clear information from
the clinical team throughout the entire process of decision-
making [34-36], and the support to them/their child from
the clinical team [24,34,36]. For young people, facilitators
included: the provision of thoughtful care by staff [36],
getting clear information from the clinical team [36],
and receiving support from the clinical team [36]. For
oncologists, facilitators included: staff agreement on op-
tion chosen [34,36], and ability of the child and family
to understand and accept the situation [34,36].
Overarching narrative synthesis of the entire dataset and
development of a theoretical framework
The overarching narrative synthesis focused on moving
beyond the thematic analysis to mapping ideas and gen-
erating and interrogating relationships in the synthesised
body of evidence with Howard’s model in order to develop
a theoretical framework of the positive and negative influ-
ences on the decision-making process when the treatment
is no longer curative. The process began with privileging
factors influencing decision-making from the perspective
of the relevant actors as outlined in Figure 3, which were
then used as a basis for developing a theoretical frame-
work (Figure 4). The logic of the theoretical framework
(Figure 4) is described in the following paragraphs.
Evidence suggests that when doctors believe that their
work is to cure disease or maximize medical outcomes,
the doctor’s clinical role in decision-making is restricted
to giving the parents/children all relevant research evi-
dence on the benefits and risks of various treatment op-
tions so that they will be able to make an informed
decision alone. In the Figure 4 this notion is depicted in
the left-hand circle, at the centre of the figure. Child prog-
nosis and comorbid conditions −when treatment is no
longer curative −were the predominant motivations in the
doctors’ decision. The right-hand circle represents, theor-
etically, the subjective realm of health and illness. Bothcircles ought to be inextricably joined. Yet, the evidence
showed that doctors did not generally dig deeper to ex-
plore wider life-course determinants that may impact on a
parent’s ability to trust them. This superficial level of
doctor involvement in the relationship with the children’s
parents resulted in either lack of parental trust, or meant
that parents made substantial errors when judging their
child’s prognosis. Hence, for many parents, participating
in decision-making represented a high burden and emo-
tional distress, conflict with the clinical team, and the
constant searching for cancer directed treatments. This
resulted in children and young people who did not experi-
ence a clear and timely shift in the goals of care, from
curative to palliative, over time.
Whereas, when doctors established a collaborative re-
lationship with the child and their parents, and showed
loyalty to what parents and their children were demand-
ing of them (to be attentive to all the evidence, under-
stand the evidence intelligently, rationally judge whether
their understanding was correct, and act at the right time
based on what has been understood correctly), parents felt
understood and treated as persons. They trusted their
doctors and clinical team, thereby decreasing the emo-
tional distress, and their children experienced a timely and
clear transition from therapeutic care to palliation.
Whilst showing a trajectory of positive and negative
outcomes, it is likely that families will move along a con-
tinuum depending on the decision, the illness trajectory
and the varying perspectives of different clinicians that
they encounter. Parents’ role as protectors and their desire
to prevent harm in combination with the variety of treat-
ment options, outcomes and prognosis makes decision-
making very hard and some are likely to waver or alter
their decisions over time.
Discussion
A child’s age-appropriate competence to fully understand
and to express personal views, and the ‘best interest’ stand-
ard, is prescribed by the medico-legal and ethical guidelines
and generally followed during decision-making processes
in actual clinical practice. The term competence for assent
differs from the term competence for consent (a legally
valid authorization). Thus, according to the medico-legal
and ethical guidelines, age has conventionally been used as
an operational criterion of valid authorization. Thresholds
of age (for children under 16 years-old) vary in accordance
with a community’s standards, with the degree of risk in-
volved and with the importance of the prospective benefits.
Application of these two criteria of best practice (age-
related competence and mental capacity and best-interest
concerning decision-making towards end-of-life in chil-
dren and young people with cancer) help parents and doc-
tors arrive at what is considered by them as the best
decision for each child. Nonetheless, what constitutes the
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tives varied considerably.
To clinicians, oncologists in particular, the measures
of success or failure of treatment were predominantly
quantifiable, emphasising severity of disease and life ex-
pectancy. Moreover, the value of ‘respect for autonomy’
was understood as having to follow the ‘child/parents’
preferences’ limiting their role to information transfer (i.e.,
to give relevant information about the patient’s prognosis,
and benefits and risks of various treatments so that par-
ents were enabled to make an informed decision). Doctors
also understood that the remaining task of deliberation
and decision-making was generally the responsibility of
the parents/family alone, unless the child was legally com-
petent to make the decision. So, within this decision
frame, acting in the child’s best interest is a medical/bio-
logical choice rather than a moral choice. Hence, from the
doctors’ perspective, unrealistic parental expectations for
cure were considered to be the biggest barrier that
impacted on implementation of best-practice guidance.
Beauchamp and Childress [43] however consider that
neither the children, their parents nor their clinicians
have premier and overriding authority, and no pre-
eminent principle exists in medical ethics. Beneficence
provides the primary goal and rationale of medicine and
clinical practice, whereas respect for autonomy, along
with nonmaleficence and justice, sets moral limits on
the clinician’s actions in pursuit of this goal. To achieve
this, interpersonal relationships and the core issue of
trust between child-parent-clinicians should and ought
to be given a co-execution of the acts in which and with
which child, parents, and clinicians, execute their status
as moral agents [43]. Nonetheless, there was a notice-
able lack of evidence concerning the wider complexities
of decision-making and the complex beliefs and experi-
ences of parents that could help or hinder the process
of developing trusting relationships with clinicians. The
ability of researchers to better understand these com-
plexities is likely to depend on the availability of add-
itional evidence that provides a greater degree of insight
into these complexities from multiple informant per-
spectives using longitudinal ethnographic methods.
Similar to the present discussion of ‘best-interests stand-
ard’, the literature on this topic has previously distinguished
between best-interests standard as an absolute duty or rule,
and best-interests standard as a very general guideline;
thereby pointing to the negative effects of a deontological
approach in which ethics consists of binding rule-based
obligations that responsible actors can be expected to
know and put into practice [44]. The findings of this review
show that although doctor concern, morally speaking, has
to do what was the best for the child, the basis of their
actions was merely deontological or rule based by always
acting according to a specific view of what is ‘right’.To parents, increasing the length of life expectancy
and curing their child’s condition remained as important
goals but were not always as important as the child’s
quality of life and suffering. It was clear that, parental
treatment preferences were rooted in the quality of the
interpersonal process that occurred during consultations
and in the level and depth of the oncologists and other
clinicians’ involvement. Within the parental decision
frame, parents faced a difficult question about whether
to emphasize respecting their child’s autonomy or to pro-
tect their child from harm –a moral rather than a medical
choice. This problem becomes, for them, more difficult to
solve when doctors fail to recognise the complexity and
changeable nature of the desires, emotions, and needs that
characterise the doctor-child-parent relationship, espe-
cially during end-of-life care.
To young people, quality of life and avoiding adverse
effects was the main goal for making judgments and de-
cisions. Concern and caring about others was the most
influential factor in their treatment preferences Further-
more, similar to their parents, their treatment preferences
were rooted in the perceived quality of the interpersonal
process that occurs during consultations and in the level
and depth of the oncologists and other clinician involve-
ment. So, within the young persons decision frame, their
decision-making was moral based.
A child’s age-related competence to understand and
decide is considered as a pivotal factor for valid consent.
So, to have the ability to consent to, or refuse, treatment
means that children must be legally competent. There
exist different tests to indicate whether the child has
‘sufficient understanding and intelligence to enable him
or her to understand fully’. Nonetheless, all methods for
setting standards of competence are defined in theory-
oriented guidelines, rather than operationalised by prac-
tice oriented professionals [43,45,46]. With regard to this
issue, it was noted that findings from children did not fea-
ture strongly. Nevertheless, the empirical evidence shows
that emotional and moral aspects, such as children and
young people’s expectations about their role in choice and
decision-making, and the effects of the child’s decisional
authority on treatment decisions were not considered in
the studies reviewed.
The range of decision-making issues identified point to
the need to improve understanding of decision-making
processes in this specific context for children and young
people. Ridd et al. [47] propose three critical elements of
the doctor-patient relationship (continuity of care over
time, positive consultation experiences, and depth/in-
volvement of relationship) as indicators of the quality of
the care of adult patients. Our findings suggest that the
experience of children and young people and their par-
ents, with their clinical providers, constituted a powerful
and influential factor in the development of trust in the
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volvement impacted in the same way. Trust also appeared
as the most important ingredient for parents. Lack of trust
in the clinicians or belief in the plan of care offered were
the primary reasons for choosing to continue cancer-
directed treatment. Additionally, there were differences in
importance between the values of parents and oncologists.
Parents held values such as honesty, caring, sensitivity,
thoughtfulness, etc. highly, and they identified them as in-
fluencing their treatment preferences. In contrast, the
values held by the child’s primary oncologist had to do
with the child’s prognosis and comorbid conditions. From
the values held, it may be said that the aim sought by
parents was maximizing their understanding about prog-
nosis, and the aim of doctors was maximizing medical
outcomes. These findings confirm what some clinicians
have said about decision-making, that values, feelings,
skills, and personal background, make evident why one
thinks and acts as one does [1,48]. Therefore, it is strongly
recommended that a deeper level of doctor (and wider
clinical team) involvement should include asking about
feelings and acknowledging and legitimizing emotions, to
assist in exploring the thoughts that parents/children have
about hopes for their future.
Limitations
The majority of empirical research about the decision-
making process when cancer treatment is no longer
curative, in children and young people, is based primar-
ily upon interviews with bereaved parents (≤5 years after
their children died), and to a lesser extent, interviews
with children’s primary oncologists, and medical record
reviews. Most parents (n = 530/629, 84%), young people
(n = 14/20, 70%), and clinicians (n = 142/236, 60%) were
female. Only one study [36] included the words of the
child. All studies were carried out in high income coun-
tries (US, Canada, UK, Germany, Australia, and Hong
Kong) and with English speakers. Given the centrality of
values, beliefs and patterns of communication during the
treatment decision-making process, it is possible that a
different picture could have emerged from a population
sample that represented middle-income and developing
countries.
There were also some important knowledge gaps, and
gaps in understanding in the available evidence. Although
the voice of the child and the child’s increasing autonomy
over time as they grow up is an important consideration,
evidence did not shed much light on developmental as-
pects of decision-making, nor did children and young
people with cognitive impairments feature in included
studies. This issue is relevant as many children and young
people gain mental capacity to make decisions as they
grow up but can lose capacity or ability to engage with
decision-making as their condition worsens. Many childrenand young people experience critical lapses in their condi-
tion which would mean their parents having to act as sole
decision-makers working with their clinicians either
permanently or until a point is reached when the child
recovers sufficiently to re-engage in decision-making on
some level.
Clinician perspectives are currently more likely to be
captured in large quantitative surveys than in high qual-
ity and rich ethnographic qualitative research. Quantita-
tive surveys are more likely to reflect the values of the
researchers than the researched. Also worthy of mention
is the notion that a reliance on key tenets of ethical
practice may over privilege ‘top down’ guidelines as a
source of moral authority. Counteracting this notion of
‘over privileging’ is the process by which many of the
guidelines were developed by consensus and subjected
to extensive public consultation. In addition, by includ-
ing observations from those close to the realities and
complexities of real life clinical practice, additional valu-
able insights into the clinical application of guidelines
are incorporated into the synthesis.
Although the low number of medico-legal cases indi-
cate that fundamental differences in opinion between ac-
tors are rare, it is likely that parents and their children
will not always agree on aspects of decisions or specific
choices, options and decisions for some or all of the
time. Likewise, biological parents may not hold the same
ideas and aspirations for their child’s care and treatment,
and decision-making may be complicated further if step-
parents and reconstituted family structures are involved.
Parents and children, either individually or collectively,
may change their minds about the best course of action
over time. Similarly, parents used to making decisions
for their young children may experience difficulties hav-
ing to accommodate their growing children in the
decision-making process as their child’s autonomy and
understanding increases. Nonetheless, the evidence is
not sufficiently nuanced to draw out different actor per-
spectives, decision-making contexts, or to differentiate
between subtle or marked differences in opinion, nor the
processes by which these differences may or may not be
overcome in the decision-making process. There is also
far more evidence from parents and the child’s perspec-
tive is critically under researched and under represented.
The single study that did however include children and
young people’s views and experiences provided a snap-
shot of how they were positioned in the decision-making
process at different ages, and some important insights
such as the altruism of some children wanting others to
benefit from their experience.
There is a wealth of evidence from studies undertaken
with children and young people with non-cancer life-
limiting conditions indicating there are major chal-
lenges in the way clinicians communicate, exchange
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decision-making processes [49]. There is as yet insuffi-
cient evidence to show whether these same challenges
exist in situations when cancer care is no longer cura-
tive. In developing the theoretical model there was in-
sufficient evidence to locate the child or even the young
person age 16-18 years as potentially having a spectrum
of different age and developmentally-appropriate views,
opinions and experiences from their parents, and there
was insufficient evidence to differentiate parental views
or reconstituted family contexts whereby the child may
have separated or additional step parents who may con-
tribute to the decision-making process. Wider family
perspectives (such as siblings) are also largely absent.
The fact that evidence mainly comes from parents and
doctors, indicates that the complexity of decision making
by relevant actors is not well understood as a non-linear
longitudinal process involving a large multi-disciplinary
team spanning hospital and primary care (including the
child’s general practitioner, for example). Although the
leading role in diagnosis and the selection of therapeutic
procedures falls on the oncologist, children and their par-
ents meet frequently with a large multi-disciplinary team
in different settings and for different reasons. Specialist
nurses are integrated members of the multi-disciplinary
team who are trained in child-centred communication
and family support and yet their perspectives are largely
absent from literature.
The conduct of research and recruitment of children
with cancer at the terminal stage is acknowledged as be-
ing ethically and technically highly challenging. None-
theless, the few young people who were consulted had
as their goal a willingness to help other children by par-
ticipating in research. The ethical challenges preventing
inclusion of children and young people in research draw
attention to the child as an inchoate participant in a social
reality, rather than as an isolated and vulnerably entity, in
which both protection of vulnerability and contribution to
the good of children generally and society specifically
ought be considered. Although technically challenging
and varying in quality all of the studies were considered of
reasonable quality to include in the review. All the studies,
except three, were cross-sectional in design; and none
of them reported sample size for quantitative studies or
data saturation for qualitative studies thereby indicating
the need for better designed and reported studies in the
future.
Finally, key aspects of decision-making remain unex-
plored, such as information processing, voluntary nature
(or not) of autonomous action and decisions made, and
the ethical nature of medical and clinical work. More
empirical work is therefore needed to find out how
particular values, either professional or personal, mani-
fest themselves in clinical practice. To research therelationship between individual and organizational eth-
ical values (such as religious affiliation) would also help
to explore the nature of decision-making in greater depth.
Here again, interpersonal, comparative empirical research
could reveal much about the similarities and differences
between organizations and individual practice, and how
these values interact in positive and negative ways on
decision-making in this context.
Conclusion
The findings of this review provide valuable, critical and
new theoretical insights into how the decision-making
processes are understood and constructed by the main
actors when the decisions are of great consequence to
the child and their family at the moment when treat-
ment is no longer curative. It also provides impetus for
more effective implementation of the ethics of profes-
sionalism in daily clinical practice thereby reinforcing
the practice of good medicine. Ethical guidelines and
regulations attempt to bring doctors together by articu-
lating shared values. But, while important, ethics training
must be supported by other institutional/organizational
measures to assist doctors to achieve and maintain good
professional standards. Findings will hopefully stimulate
further normative and descriptive lines of research in
this complex, under-researched, field through a wider
cultural lens that includes children’s perspectives. The
wider view will characterize and understand more fully
the dynamics of the decision-making process in this spe-
cific end-of life context.
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